These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1673097)

  • 1. The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failure.
    Blanchett DG; Green JA; Nara A; Pospisil R; Jarvis RC; Kasmer RJ; Boyle DA; Cyronak MJ; Corder CN
    Clin Pharmacol Ther; 1991 Apr; 49(4):449-56. PubMed ID: 1673097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure.
    Munger MA; Benotti JR; Green JA; Jarvis RC; Nara AR; McCue JE; Pospisil RA; Kasmer RJ
    Am J Cardiol; 1990 Jan; 65(3):206-10. PubMed ID: 1967511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis.
    Vlavianos P; Polson RJ; Settin A; Glover J; Westaby D; Williams R
    Br J Clin Pharmacol; 1990 Jan; 29(1):19-25. PubMed ID: 1967532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.
    Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R
    Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction study of fenoldopam--digoxin in congestive heart failure.
    Strocchi E; Tartagni F; Malini PL; Valtancoli G; Ambrosioni E; Pasinelli F; Riva E; Fuccella LM
    Eur J Clin Pharmacol; 1989; 37(4):395-7. PubMed ID: 2574674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs.
    Kien ND; Moore PG; Jaffe RS
    Anesth Analg; 1992 Jan; 74(1):72-8. PubMed ID: 1346487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
    Aronson S; Goldberg LI; Glock D; Roth S; Moss J; Roizen MF
    J Cardiothorac Vasc Anesth; 1991 Feb; 5(1):29-32. PubMed ID: 1678284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
    Francis GS; Wilson BC; Rector TS
    Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
    Eades SC; Moore JN
    Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
    Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failure.
    Young JB; Leon CA; Pratt CM; Suarez JM; Aronoff RD; Roberts R
    J Am Coll Cardiol; 1985 Oct; 6(4):792-6. PubMed ID: 2863295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
    Bodmann KF; Tröster S; Clemens R; Schuster HP
    Clin Investig; 1993 Dec; 72(1):60-4. PubMed ID: 7907900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
    Polak MJ; Drummond WH
    Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.